Recent advances in platelet growth factors / 中国病理生理杂志
Chinese Journal of Pathophysiology
; (12): 285-288, 2001.
Article
em Zh
| WPRIM
| ID: wpr-410842
Biblioteca responsável:
WPRO
ABSTRACT
Currently, platelet transfusion is the primary treatment for thrombocytopnia which results from intensive chemotherapy and radiotherapy of cancer. While repeated platelet transfusions are associated with several problems. The clinical availability of safe and effective platelet growth factors is eagerly awaited. Currently, a mumber of hematopoietic growth factors with thrombopoietic activity have been identified. This review discusses the biological characteristics and the clinical trial investigation development of platelet growth factors.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Pathophysiology
Ano de publicação:
2001
Tipo de documento:
Article